A newly published study in the British Medical Journal says that the US–UK pharmaceutical deal agreed last December could lead to 229,000 excess deaths in England by 2036 if the NHS has to divert money from other services to pay for it. That’s more than the 137,000 deaths recorded during the...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.